Skip to main content

Induced Pluripotent Stem Cells

  • Living reference work entry
  • First Online:
Encyclopedia of Psychopharmacology
  • 111 Accesses

Synonyms

IPSC

Definition

Induced pluripotent stem cells (iPSCs) are pluripotent cells that have been “reprogrammed” from differentiated somatic cells. Most cells in the adult body are differentiated, that is, they have adopted a particular cellular fate and cannot generally turn into cells of any other type. Stem cells by contrast are able to generate a range of cell types, while pluripotent stem cells have the singular ability to generate any cell type in the body. “Reprogramming,” therefore, brings about the dramatic transformation of a somatic cell, whose fate is terminal and fixed, to a pluripotential cell that has the potential to generate any cell type in the body. Since this includes nerve cells, iPSCs present a means of generating human neurons in a tissue culture dish.

Current Concepts and State of Knowledge

History of iPSCs

iPSCs technology dates from 2006, when Takahashi and Yamanaka described a technique to derive pluripotent cells from mouse skin fibroblasts (Takahashi and...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Brennand KJ, Simone A, Tran N, Gage FH (2012) Modeling psychiatric disorders at the cellular and network levels. Mol Psychiatry 17:1239–1253

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Grskovic M, Javaherian A, Strulovici B, Daley GQ (2011) Induced pluripotent stem cells — opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 10:915–929

    CAS  PubMed  Google Scholar 

  • Marchetto MCN, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y, Chen G, Gage FH, Muotri AR (2010) A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143:527–539

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Paşca SP, Portmann T, Voineagu I, Yazawa M, Shcheglovitov A, Paşca AM, Cord B, Palmer TD, Chikahisa S, Nishino S, Bernstein JA, Hallmayer J, Geschwind DH, Dolmetsch RE (2011) Using C-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med 17:1657–1662

    Article  PubMed Central  PubMed  Google Scholar 

  • Rajamohan D, Matsa E, Kalra S, Crutchley J, Patel A, George V, Denning C (2012) Current status of drug screening and disease modelling in human pluripotent stem cells. Bioessays 35:281–298

    Article  PubMed Central  PubMed  Google Scholar 

  • Shcheglovitov A, Shcheglovitova O, Yazawa M, Portmann T, Sebastiano V, Krawisz A, Froehlich W, Bernstein JA, Hallmayer J, Dolmetsch R (2013) SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 503:267–271

    CAS  PubMed  Google Scholar 

  • Shi Y, Kirwan P, Smith J, MacLean G, Orkin SH, Livesey FJ (2012) A human stem cell model of early Alzheimer’s disease pathology in down syndrome. Sci Transl Med 4:124ra29–124ra29

    PubMed  Google Scholar 

  • Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676

    Article  CAS  PubMed  Google Scholar 

  • Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872

    Article  CAS  PubMed  Google Scholar 

  • Vierbuchen T, Ostermeier A, pang ZP, Kokubu Y, Südhof TC, Wernig M (2010) Nature 463:1035–1041

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jack Price .

Editor information

Editors and Affiliations

Glossary

Blastocyst

An early-stage mammalian embryo, reached after about 5 days in human development, composed of a few hundred cells

Copy Number Variant (CNV)

A copy number variant is a change in the structure of the genome whereby a genetic sequence is either deleted or duplicated. Consequently, the carrier of the CNV will have more or fewer copies of certain genes than expected

Embryonic Stem Cells (ES Cells)

ES cells are pluripotent stem cells derived directly from the embryo. So unlike iPSCs, whose pluripotentiality is artificially induced by reprogramming, ES cells are derived directly from naturally pluripotent cells

High-Content Screening

High-content screening is an approach to drug discovery whereby the effect of compounds on multiple phenotypic properties of cells is analyzed simultaneously, frequently involving image analysis using fluorescent tags

Inner Cell Mass

The inner cell mass is the small cluster of transiently pluripotential cells in the early mammalian embryo, from which all the cell types of the body are derived

Non-integrating Vectors

Vectors which transfer genetic material into cells, but which do not themselves integrate into the human nuclear DNA. Because they do not integrate, they do not damage the genome, and they disappear from the cell in time, thereby reducing any problems that might result from the presence of an extraneous DNA sequence in the cell

Pluripotent

Having the potential to generate all the cell types in the body

Reprogramming

The transition from a differentiated or committed phenotype to a more primitive, less-differentiated state

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Price, J. (2014). Induced Pluripotent Stem Cells. In: Stolerman, I., Price, L. (eds) Encyclopedia of Psychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27772-6_7013-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27772-6_7013-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27772-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics